Form 4: Repligen Corp Director Rohin Mhatre Acquires Shares and Stock Options

Director Rohin Mhatre acquired 701 restricted stock units and stock options for 1,376 shares of Repligen Corp on May 16, 2024.

Summary

• On May 16, 2024, Rohin Mhatre, a director of Repligen Corp, acquired 701 restricted stock units, each representing a contingent right to receive one share of Repligen's common stock.
• Mhatre also acquired stock options for 1,376 shares with an exercise price of $171.03.
• The restricted stock units vest on the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders.
• Following the transaction, Mhatre directly owns 3,046 shares of Repligen Corp common stock and options for 1,376 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The acquisition of shares and options could be interpreted as a positive sign, but it's not a strong indicator.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting of the restricted stock units and stock options is contingent on the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders, which has not yet been determined.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future performance.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates